Clinical Trial Update: A Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan in Second-Line and Subsequent Treatments for Advanced Thymic Epithelial Tumors [Phase 2]

View source ↗

Summary

A single-arm Phase II clinical trial is evaluating the efficacy and safety of Sacituzumab Tirumotecan in patients with advanced thymic epithelial tumors who are…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Epithelial Tumors

Drugs mentioned

• Sacituzumab Tirumotecan (Sacituzumab govitecan)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Thymic Epithelial Tumors, Advanced Stage | Phase 2 | Status: NOT_YET_RECRUITING